Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Return on Sales (2020 - 2025)

Pulse Biosciences has reported Return on Sales over the past 5 years, most recently at 643.36% for Q4 2025.

  • Quarterly results put Return on Sales at 643.36% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 643.36% (changed N/A YoY), and the annual figure for FY2022 was 83.58%, down 3811.0%.
  • Return on Sales for Q4 2025 was 643.36% at Pulse Biosciences, down from 225.19% in the prior quarter.
  • Over the last five years, Return on Sales for PLSE hit a ceiling of 164.5% in Q1 2021 and a floor of 643.36% in Q4 2025.
  • Median Return on Sales over the past 4 years was 43.18% (2022), compared with a mean of 100.26%.
  • Biggest five-year swings in Return on Sales: surged 227300bps in 2021 and later plummeted -20768bps in 2022.
  • Pulse Biosciences' Return on Sales stood at 18.66% in 2021, then crashed by -348bps to 83.58% in 2022, then crashed by -104bps to 170.11% in 2023, then crashed by -278bps to 643.36% in 2025.
  • The last three reported values for Return on Sales were 643.36% (Q4 2025), 225.19% (Q3 2025), and 170.11% (Q1 2023) per Business Quant data.